SCHEMBL206689

SCHEMBL206689

CCCCCCCCOc1ccc(Nc2nc(-c3ccc(F)c(F)c3)cs2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 6/20 0.46
PTGES O14684 2/20 0.46
PPARG P37231 1/20 0.46
PPARA Q07869 1/20 0.46
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
RAB9A P51151 3/20 0.42
HPGDS O60760 1/20 0.41
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
NPC1 O15118 2/20 0.41
MAPT P10636 2/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
CYP1B1 Q16678 1/20 0.41
PTGS2 P35354 2/20 0.41
NPY5R Q15761 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL207120 0.90 ALOX5 (0.53) ALOX5MEN1KMT2ARAB9ANPC1
SCHEMBL205681 0.89 ALOX5 (0.54) ALOX5MEN1KMT2ARAB9ANPC1
SCHEMBL206705 0.87 ALOX5 (0.54) ALOX5PTGESPPARGPPARAMEN1
SCHEMBL205801 0.86 CYP1A1 (0.54) ALOX5MEN1KMT2ARAB9ANPC1
SCHEMBL2706495 0.86 ALOX5 (0.55) ALOX5PTGESPPARGPPARAMEN1
SCHEMBL208154 0.86 ALOX5 (0.56) ALOX5MEN1KMT2ARAB9ANPC1
SCHEMBL207764 0.85 ALOX5 (0.55) ALOX5PTGESMEN1KMT2AMAPT
SCHEMBL206783 0.84 MEN1 (0.46) ALOX5MEN1KMT2ARAB9ANPC1
SCHEMBL205809 0.83 AGER (0.52) ALOX5PTGESPPARGMEN1KMT2A
SCHEMBL206060 0.82 PTGES (0.46) ALOX5PTGESPPARGPPARAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US claimed
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE PIGS, CPT1A, SLC10A1 ALOX5 3410/4885PTGES 2882/4885PPARG 597/4885
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 ALOX5 3410/4885PTGES 2882/4885PPARG 597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.